亿帆医药：亿立舒目前处于初期的导入爬坡阶段

Group 1 - The core viewpoint is that Yifan Pharmaceutical (002019) acknowledges that the sales of innovative drugs require a certain cultivation period, indicating that the product Yilishu is currently in the initial ramp-up phase [1] - The company states that it should be able to fulfill the binding procurement volume of over 40,000 units [1]